You have 9 free searches left this month | to do more
Showing 1 - 25 of
>10,000 items
Trials Per Page
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
D
Active, not recruiting
  • Hodgkin's Disease
  • Echo/Stress Echo
  • Boston, Massachusetts
  • +1 more
2022-03-28
Mar 28, 2022
S
Recruiting
  • Lymphoma, Non-Hodgkin
  • Hodgkin's Disease
    • Stanford, California
      Stanford University School of Medicine
    2021-08-02
    Aug 2, 2021
    N
    Completed
    • HIV Infections
    • Hodgkin's Disease
    • Vinblastine sulfate
    • +4 more
    • Birmingham, Alabama
    • +7 more
    2021-10-26
    Oct 26, 2021
    C
    Terminated
    • Carotid Artery Disease
    • New York, New York
      Columbia Univeristy Medical Center
    2021-02-10
    Feb 10, 2021
    B
    Completed
    • Hodgkin's Disease
      • Louisville, Kentucky
        Norton Cancer Institute
      2021-12-14
      Dec 14, 2021
      S
      Completed
      • CD20+, B-cell Lymphomas
      • +5 more
      • Baltimore, Maryland
        Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
      2021-10-04
      Oct 4, 2021
      U
      Not yet recruiting
      • Young Adults
      • +2 more
      • Indirect calorimetric test during submaximal exercise
      • Clermont-Ferrand, France
        CHU de Clermont-Ferrand
      2021-12-27
      Dec 27, 2021
      S
      Completed
      • Hodgkin Lymphoma
      • 12 Week Stanford V Chemotherapy
      • +3 more
      • Palo Alto, California
      • +4 more
      2021-11-23
      Nov 23, 2021
      D
      Recruiting
      • Non-Hodgkin's Lymphoma
      • +3 more
        • Boston, Massachusetts
          Dana-Farber Cancer Institute
        2021-07-14
        Jul 14, 2021
        B
        Active, not recruiting
        • Lymphoma
        • +3 more
        • TGFbeta resistant LMP-specific CTLs
        • Houston, Texas
        • +1 more
        2021-12-08
        Dec 8, 2021
        T
        Active, not recruiting
        • Untreated CD30-Positive Hodgkin's Lymphoma
        • Brentuximab vedotin (Genetical Recombination)
        • Tokyo, Japan
          Takeda Selected Site
        2022-03-24
        Mar 24, 2022
        I
        Terminated
        • Hodgkin's Lymphoma
        • histone deacetylase inhibitor (ITF2357)
        • Milan, Italy
          Istituto Nazionale per lo studio e la cura dei Tumori
        2022-01-18
        Jan 18, 2022
        S
        Completed
        • Lymphoma
        • Bleomycin sulfate
        • +7 more
        • Stanford, California
          Stanford Cancer Center at Stanford University Medical Center
        2020-08-10
        Aug 10, 2020
        B
        Recruiting
        • Hodgkin's Disease
        • +3 more
        • EBV-specific T cells: A
        • EBV-specific T cells: B
        • Houston, Texas
        • +1 more
        2021-11-10
        Nov 10, 2021
        D
        Completed
        • Lung Cancer
        • chest computed tomography scan
        • Boston, Massachusetts
        • +1 more
        2020-01-09
        Jan 9, 2020
        M
        Completed
        • Lymphoma
        • Houston, Texas
          University of Texas MD Anderson Cancer Center
        2019-12-13
        Dec 13, 2019
        J
        Completed
        • Hodgkin Lymphoma, Adult
        • Beijing, Beijing, China
          Beijing Cancer Hospital
        2021-10-29
        Oct 29, 2021
        W
        Recruiting
        • Acute Myelogenous Leukemia
        • +9 more
          • Winston-Salem, North Carolina
            Wake Forest Baptist Health
          2021-11-23
          Nov 23, 2021
          N
          Recruiting
          • Relapsed/Refractory Classical Hodgkin Lymphoma
          • Brentuximab vedotin
          • Goyang, Gyeonggi-do, Korea, Republic of
            Hyeon-Seok Eom
          2022-02-12
          Feb 12, 2022
          C
          Completed
          • Hodgkin's Disease
          • Non-Hodgkin's Lymphoma
          • New York, New York
            Center for Lymphoid Malignancies at CUMC
          2020-11-05
          Nov 5, 2020
          U
          Active, not recruiting
          • Non-Hodgkin's Lymphoma
          • Hodgkin's Lymphoma
          • CAR.CD30 T cells
          • Chapel Hill, North Carolina
          • +2 more
          2022-03-16
          Mar 16, 2022
          U
          Completed
          • Hodgkin Disease
          • Lymphoma, Non-Hodgkin
          • Survey
          • Rochester, New York
            University of Rochester Medical Center
          2021-03-04
          Mar 4, 2021
          I
          Completed
          • Hodgkin's Lymphoma
          • Milano, Italy
            Istituto Nazionale per la Cura e lo Studio dei Tumori
          2021-04-20
          Apr 20, 2021